Forsyth PA - Search Results

1

Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.

Rodrigues JC, Gonzalez GC, Zhang L, Ibrahim G, Kelly JJ, Gustafson MP, Lin Y, Dietz AB, Forsyth PA, Yong VW, Parney IF. Rodrigues JC, et al. Among authors: forsyth pa. Neuro Oncol. 2010 Apr;12(4):351-65. doi: 10.1093/neuonc/nop023. Epub 2009 Dec 22. Neuro Oncol. 2010. PMID: 20308313 Free PMC article.

2

Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.

Nuttall RK, Pennington CJ, Taplin J, Wheal A, Yong VW, Forsyth PA, Edwards DR. Nuttall RK, et al. Among authors: forsyth pa. Mol Cancer Res. 2003 Mar;1(5):333-45. Mol Cancer Res. 2003. PMID: 12651907

3

The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.

Zhou Y, Zhang J, Liu Q, Bell R, Muruve DA, Forsyth P, Arcellana-Panlilio M, Robbins S, Yong VW. Zhou Y, et al. Carcinogenesis. 2005 Dec;26(12):2058-68. doi: 10.1093/carcin/bgi182. Epub 2005 Jul 20. Carcinogenesis. 2005. PMID: 16033775

4

The p75 neurotrophin receptor is a central regulator of glioma invasion.

Johnston AL, Lun X, Rahn JJ, Liacini A, Wang L, Hamilton MG, Parney IF, Hempstead BL, Robbins SM, Forsyth PA, Senger DL. Johnston AL, et al. Among authors: forsyth pa. PLoS Biol. 2007 Aug;5(8):e212. doi: 10.1371/journal.pbio.0050212. PLoS Biol. 2007. PMID: 17696644 Free PMC article.

5

Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.

Sijben AE, McIntyre JB, Roldán GB, Easaw JC, Yan E, Forsyth PA, Parney IF, Magliocco AM, Bernsen H, Cairncross JG. Sijben AE, et al. Among authors: forsyth pa. J Neurooncol. 2008 Aug;89(1):97-103. doi: 10.1007/s11060-008-9593-6. Epub 2008 Apr 9. J Neurooncol. 2008. PMID: 18398569

6

Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.

Kelly JJ, Stechishin O, Chojnacki A, Lun X, Sun B, Senger DL, Forsyth P, Auer RN, Dunn JF, Cairncross JG, Parney IF, Weiss S. Kelly JJ, et al. Stem Cells. 2009 Aug;27(8):1722-33. doi: 10.1002/stem.98. Stem Cells. 2009. PMID: 19544433

7

Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience.

Lwu S, Hamilton MG, Forsyth PA, Cairncross JG, Parney IF. Lwu S, et al. Among authors: forsyth pa. J Neurooncol. 2010 Feb;96(3):403-8. doi: 10.1007/s11060-009-9977-2. Epub 2009 Aug 8. J Neurooncol. 2010. PMID: 19669097

8

Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.

Zemp FJ, Lun X, McKenzie BA, Zhou H, Maxwell L, Sun B, Kelly JJ, Stechishin O, Luchman A, Weiss S, Cairncross JG, Hamilton MG, Rabinovich BA, Rahman MM, Mohamed MR, Smallwood S, Senger DL, Bell J, McFadden G, Forsyth PA. Zemp FJ, et al. Among authors: forsyth pa. Neuro Oncol. 2013 Jul;15(7):904-20. doi: 10.1093/neuonc/not035. Epub 2013 Apr 12. Neuro Oncol. 2013. PMID: 23585629 Free PMC article.

9

Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells.

Sarkar S, Döring A, Zemp FJ, Silva C, Lun X, Wang X, Kelly J, Hader W, Hamilton M, Mercier P, Dunn JF, Kinniburgh D, van Rooijen N, Robbins S, Forsyth P, Cairncross G, Weiss S, Yong VW. Sarkar S, et al. Nat Neurosci. 2014 Jan;17(1):46-55. doi: 10.1038/nn.3597. Epub 2013 Dec 8. Nat Neurosci. 2014. PMID: 24316889

10

Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.

Zemp FJ, McKenzie BA, Lun X, Reilly KM, McFadden G, Yong VW, Forsyth PA. Zemp FJ, et al. Among authors: forsyth pa. Cancer Res. 2014 Dec 15;74(24):7260-73. doi: 10.1158/0008-5472.CAN-14-0876. Epub 2014 Oct 21. Cancer Res. 2014. PMID: 25336188 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

225 results

Search Page